Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Feb 5:15:1526669.
doi: 10.3389/fonc.2025.1526669. eCollection 2025.

Editorial: Updates on the management of glioblastoma

Dorota Lubanska  1   2 , Sameh Elmorsy Hassan  3 , Lisa A Porter  1   2   4   5 , Mohamed A R Soliman  6   7
Affiliations
Editorial

Editorial: Updates on the management of glioblastoma

Dorota Lubanska et al. Front Oncol. .
No abstract available

Keywords: diagnostic technology; glioblastoma; imaging; immunotherapy; prognostic markers; therapeutic efficacy assessment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Figures

Figure 1
Figure 1
Overview of the specific content and subject areas of the management of glioblastoma included in the Research Topic. This Research Topic showcases a wide variety of studies which discuss novel findings and diagnostic tools related to immunotherapy, but also consolidates new additional data of high importance to the management of glioblastoma. Combination therapy approaches including those utilizing nanosystems are discussed for targeting of glioblastoma recurrence in the case study by Zhong et al., and in the original article by Abu-Serie et al. Zhu et al. employ machine learning models to optimize adjuvant treatment options. Novel diagnostic measures are explored with the use of SERS (Yang et al.) and the analysis of specific anatomical tumor location (Meyer et al.). Chen L. et al. and Tang et al. demonstrate the potential of MRI-based radiomics-mediated detection of TERT mutations and temporal muscle thickness, respectively, as novel prognostic markers, further exemplifying the diversity of the research conducted in the Research Topic. Created in https://BioRender.com.
See this image and copyright information in PMC

Comment on

  • Editorial on the Research Topic Updates on the management of glioblastoma

References

    1. Kanderi T, Munakomi S, Gupta V. Glioblastoma Multiforme. In: StatPearls. StatPearls Publishing, Treasure Island (FL: (2024). - PubMed
    1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al. . Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. (2005) 352:987–96. doi: 10.1056/NEJMoa043330 - DOI - PubMed
    1. Dymova MA, Kuligina EV, Richter VA. Molecular mechanisms of drug resistance in glioblastoma. Int J Mol Sci. (2021) 22:6385. doi: 10.3390/ijms22126385 - DOI - PMC - PubMed
    1. Peres N, Lepski GA, Fogolin CS, Evangelista GCM, Flatow EA, de Oliveira JV, et al. . Profiling of tumor-infiltrating immune cells and their impact on survival in glioblastoma patients undergoing immunotherapy with dendritic cells. Int J Mol Sci. (2024) 25:5275. doi: 10.3390/ijms25105275 - DOI - PMC - PubMed
    1. Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, et al. . Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer Cell. (2017) 32:42–56.e6. doi: 10.1016/j.ccell.2017.06.003 - DOI - PMC - PubMed

Publication types

LinkOut - more resources